Singapore markets closed

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.7300+0.0100 (+0.37%)
At close: 04:00PM EDT
2.7300 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4453
Avg. Estimate-0.11-0.11-0.45-0.53
Low estimate-0.13-0.14-0.6-0.68
High estimate-0.1-0.09-0.38-0.43
Year ago EPS-0.1-0.1-0.44-0.45
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3343
Avg. Estimate2.15M2.17M7.76M10.02M
Low estimate2.1M2.1M4.6M8.6M
High estimate2.21M2.28M9.27M10.88M
Year ago sales6.69M4.65M18.14M7.76M
Sales growth (year/est)-67.80%-53.30%-57.20%29.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.14-0.11-0.11-0.12
Actual EPS-0.1-0.1-0.12-0.12
Difference0.040.01-0.010
Surprise %28.60%9.10%-9.10%0.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.11-0.11-0.45-0.53
7 days ago-0.11-0.11-0.45-0.53
30 days ago-0.11-0.11-0.45-0.53
60 days ago-0.1-0.1-0.43-0.38
90 days ago-0.1-0.1-0.43-0.38
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABUSIndustrySector(s)S&P 500
Current qtr.-10.00%N/AN/AN/A
Next qtr.-10.00%N/AN/AN/A
Current year-2.30%N/AN/AN/A
Next year-17.80%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A